Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis

INTRODUCTION: Liver fibrosis represents a serious global disease with no approved treatment. Tanshinone IIA (TSIIA) is a phytomedicine with documented activity in treating many hepatic disorders. TSIIA has been reported to have potent anti-inflammatory and antioxidant properties. It can also induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashour, Asmaa A, El-Kamel, Amal H, Abdelmonsif, Doaa A, Khalifa, Hoda M, Ramadan, Alyaa A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671377/
https://www.ncbi.nlm.nih.gov/pubmed/34916792
http://dx.doi.org/10.2147/IJN.S331690

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671377/
https://www.ncbi.nlm.nih.gov/pubmed/34916792
http://dx.doi.org/10.2147/IJN.S331690

Ejemplares similares